Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Endogenous glucose production is inhibited by the adipose-derived protein Acrp30
Terry P. Combs, … , Philipp E. Scherer, Luciano Rossetti
Terry P. Combs, … , Philipp E. Scherer, Luciano Rossetti
Published December 15, 2001
Citation Information: J Clin Invest. 2001;108(12):1875-1881. https://doi.org/10.1172/JCI14120.
View: Text | PDF
Article

Endogenous glucose production is inhibited by the adipose-derived protein Acrp30

  • Text
  • PDF
Abstract

Intraperitoneal injection of purified recombinant Acrp30 lowers glucose levels in mice. To gain insight into the mechanism(s) of this hypoglycemic effect, purified recombinant Acrp30 was infused in conscious mice during a pancreatic euglycemic clamp. In the presence of physiological hyperinsulinemia, this treatment increased circulating Acrp30 levels by approximately twofold and stimulated glucose metabolism. The effect of Acrp30 on in vivo insulin action was completely accounted for by a 65% reduction in the rate of glucose production. Similarly, glucose flux through glucose-6-phosphatase (G6Pase) decreased with Acrp30, whereas the activity of the direct pathway of glucose-6-phosphate biosynthesis, an index of hepatic glucose phosphorylation, increased significantly. Acrp30 did not affect the rates of glucose uptake, glycolysis, or glycogen synthesis. These results indicate that an acute increase in circulating Acrp30 levels lowers hepatic glucose production without affecting peripheral glucose uptake. Hepatic expression of the gluconeogenic enzymes phosphoenolpyruvate carboxykinase and G6Pase mRNAs was reduced by more than 50% following Acrp30 infusion compared with vehicle infusion. Thus, a moderate rise in circulating levels of the adipose-derived protein Acrp30 inhibits both the expression of hepatic gluconeogenic enzymes and the rate of endogenous glucose production.

Authors

Terry P. Combs, Anders H. Berg, Silvana Obici, Philipp E. Scherer, Luciano Rossetti

×

Total citations by year

Year: 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 Total
Citations: 5 9 8 11 16 11 8 5 10 9 16 15 17 8 17 11 15 12 12 11 5 7 10 1 249
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article in year 2009 (15)

Title and authors Publication Year
Lipopolysaccharide inhibition of glucose production through the Toll-like receptor-4, myeloid differentiation factor 88, and nuclear factor kappa b pathway
CF Raetzsch, NL Brooks, JM Alderman, KS Moore, PA Hosick, S Klebanov, S Akira, JE Bear, AS Baldwin, N Mackman, TP Combs
Hepatology 2009
Perspectives on Adipose Tissue, Chagas Disease and Implications for the Metabolic Syndrome
F Nagajyothi, MS Desruisseaux, LA Jelicks, FS Machado, S Chua, PE Scherer, HB Tanowitz
Interdisciplinary Perspectives on Infectious Diseases 2009
The Endocannabinoid System: Potential for Reducing Cardiometabolic Risk
HN Ginsberg, SC Woods
Obesity 2009
Adipocyte CREB promotes insulin resistance in obesity
L Qi, M Saberi, E Zmuda, Y Wang, J Altarejos, X Zhang, R Dentin, S Hedrick, G Bandyopadhyay, T Hai, J Olefsky, M Montminy
Cell Metabolism 2009
Obesity, airway hyperresponsiveness, and inflammation
SA Shore
Journal of applied physiology 2009
A novel pathway of insulin sensitivity in chromogranin A null mice: a crucial role for pancreastatin in glucose homeostasis
JR Gayen, M Saberi, S Schenk, N Biswas, SM Vaingankar, WW Cheung, SM Najjar, DT O'Connor, G Bandyopadhyay, SK Mahata
The Journal of biological chemistry 2009
Serum adiponectin, C-peptide and leptin and risk of symptomatic benign prostatic hyperplasia: results from the Prostate Cancer Prevention Trial
JM Schenk, AR Kristal, ML Neuhouser, CM Tangen, E White, DW Lin, IM Thompson
The Prostate 2009
A rabbit model of pediatric nonalcoholic steatohepatitis: the role of adiponectin
JF Fu, YL Fang, L Liang, CL Wang, F Hong, GP Dong
World journal of gastroenterology : WJG 2009
Identification and characterization of CTRP9, a novel secreted glycoprotein, from adipose tissue that reduces serum glucose in mice and forms heterotrimers with adiponectin
GW Wong, SA Krawczyk, C Kitidis-Mitrokostas, G Ge, E Spooner, C Hug, R Gimeno, HF Lodish
The FASEB Journal 2009
MATERNAL SERUM ADIPONECTIN MULTIMERS IN PATIENTS WITH A SMALL-FOR-GESTATIONAL-AGE NEWBORN
S Mazaki-Tovi, R Romero, E Vaisbuch, O Erez, P Mittal, T Chaiworapongsa, SK Kim, P Pacora, L Yeo, F Gotsch, Z Dong, BH Yoon, SS Hassan, JP Kusanovic
Journal of Perinatal Medicine 2009
Maternal Serum Adiponectin Multimers In Gestational Diabetes
S Mazaki-Tovi, R Romero, E Vaisbuch, O Erez, P Mittal, T Chaiworapongsa, SK Kim, P Pacora, L Yeo, F Gotsch, Z Dong, BH Yoon, SS Hassan, JP Kusanovic
Journal of Perinatal Medicine 2009
Neuroendocrine inhibition of glucose production and resistance to cancer in dwarf mice
JM Alderman, K Flurkey, NL Brooks, SB Naik, JM Gutierrez, U Srinivas, KB Ziara, L Jing, G Boysen, R Bronson, S Klebanov, X Chen, JA Swenberg, M Stridsberg, CE Parker, DE Harrison, TP Combs
Experimental Gerontology 2009
Dysregulation of maternal serum adiponectin in preterm labor
S Mazaki-Tovi, R Romero, E Vaisbuch, O Erez, P Mittal, T Chaiworapongsa, SK Kim, P Pacora, L Yeo, F Gotsch, Z Dong, CL Nhan-Chang, C Jodicke, BH Yoon, SS Hassan, JP Kusanovic
Journal of Maternal-Fetal and Neonatal Medicine 2009
Proangiogenic Contribution of Adiponectin toward Mammary Tumor Growth In vivo
S Landskroner-Eiger, B Qian, ES Muise, AR Nawrocki, JP Berger, EJ Fine, W Koba, Y Deng, JW Pollard, PE Scherer
Clinical cancer research 2009
Chagas disease, adipose tissue and the metabolic syndrome.
Nagajyothi F, Desruisseaux MS, Weiss LM, Chua S, Albanese C, Machado FS, Esper L, Lisanti MP, Teixeira MM, Scherer PE, Tanowitz HB
2009

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts